A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients
Kowalski, Mark, Entwistle, Jocelyn, Cizeau, Jeannick, Demi Niforos, Loewen, Shauna, Chapman, Wendy, MacDonald, Glen C
Published in Drug design, development and therapy (15.11.2010)
Published in Drug design, development and therapy (15.11.2010)
Get full text
Journal Article
Results of a first-in-human phase I study of SRF231, a fully human, high-affinity anti-CD47 antibody
Patnaik, Amita, Spreafico, Anna, Paterson, Alison M., Peluso, Marisa, Chung, Jou-Ku, Bowers, Beth, Niforos, Demi, O'Neill, Alison M., Beeram, Muralidhar, Iafolla, Marco, Lester, Julia, Schram, Alison M.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A phase I/II study of TKM-080301, a PLK1 -targeted RNAi in patients with adrenocortical cancer (ACC)
Demeure, Michael J, Armaghany, Tannaz, Ejadi, Samuel, Ramanathan, Ramesh K., Elfiky, Aymen, Strosberg, Jonathan R., Smith, David C., Whitsett, Timothy, Liang, Winnie S., Sekar, Shobana, Carpten, John D., Fredlund, Paul, Niforos, Demi, Dye, Andrew, Gahir, Sarabjit, Semple, Sean C., Kowalski, Mark Marion
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis
Pardanani, Animesh, Gotlib, Jason, Gupta, Vikas, Roberts, Andrew W., Wadleigh, Martha, Sirhan, Shireen, Bavisotto, Linda M, Kawashima, Jun, Lee, Peter, Kowalski, Mark, Deng, Wei, Niforos, Demi, Tefferi, Ayalew
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Dose-Response Analyses Of Momelotinib (CYT387), a JAK1 and JAK2 Inhibitor, From a Phase I/II Study (CCL09101) In Treatment Of Myelofibrosis
Xin, Yan, Shao, Lixin, Deng, Wei, Niforos, Demi, Kowalski, Mark, Bavisotto, Linda M, Kawashima, Jun, Jun, Susie, Collins, Helen, Ramanathan, Srinivasan
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients
Kowalski, Mark, Entwistle, Joycelyn, Cizeau, Jeannick, Niforos, Demi, Loewen, Shauna, Chapman, Wendy, MacDonald, Glen C
Published in Drug design, development and therapy (15.11.2010)
Published in Drug design, development and therapy (15.11.2010)
Get full text
Journal Article